Quality of Life by Stage of Cervical Cancer among Malaysian Patients

Nawi, Azmawati Mohammed; Najibah, Endut; Hatta, Mohd Dali Ahmad Zailani; Ahmad, Norfazilah

doi:10.7314/apjcp.2014.15.13.5283

Cited by 20 publications

(22 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The overall life quality had a meaningful link with the stage of cervical cancer. Overall life quality was higher in stages I, II, and III compared to stage IV [23]. Research by Perwitasari (2009) shows the same result of overall life quality, in which it shows how the decrease in life quality is not significant after going through cisplatin or its combination chemotherapy [24].…”

Section: Resultsmentioning

confidence: 92%

Assessment of Life Quality in Patients With Stage Iib-Iiib Squamous Cell Cervical Cancer Receiving Paclitaxel Cisplatin Chemotherapy Regimen by Eortc QLQ-C30 Questionnaire in Sanglah Hospital Denpasar

Noviyani

Indrayathi

Budiana

et al. 2017

Int J Pharm Pharm Sci

View full text Add to dashboard Cite

Objective: Cervical cancer was the prominent cause of women's death in developing states. Decrease in life quality was often encountered by patients with cervical cancer in advanced stages. One treatment method of cervical cancer at Sanglah Hospital was using paclitaxel cisplatin chemotherapy. Information on cervical cancer patient's life quality who received paclitaxel cisplatin chemotherapy was still limited, so research was required to observe cervical cancer patients’ life quality before the first and after the sixth paclitaxel cisplatin chemotherapy regimen.Methods: Observational study with prospective case study design was undertaken at the Polyclinic of Obstetrics and Gynecology Sanglah Hospital from January to August 2016. Sampling was conducted before chemotherapy I and after chemotherapy VI using consecutive sampling method. The EORTC QLQ C30 questionnaires were completed by the patients before chemotherapy I and after chemotherapy VI. Patients' life quality who had received paclitaxel cisplatin chemotherapy were assessed with 15 domains in EORTC QLQ C30 questionnaire. The data obtained were processed with STATA® version 14 and analysed using paired t test and Wilcoxon test with a confidence level of 95%.Results: The number of samples used in this study was 7 patients who received paclitaxel cisplatin chemotherapy. The results of the analysis showed that there were differences in cervical cancer patients’ life quality who had received paclitaxel cisplatin regimen chemotherapy before chemotherapy I and after chemotherapy VI with the result of p-value is 0.0005.Conclusion: There was a significant decrease in the value of cervical cancer patients' life quality who received paclitaxel cisplatin chemotherapy before chemotherapy I and after chemotherapy VI.

show abstract

Section: Resultsmentioning

confidence: 92%

Assessment of Life Quality in Patients With Stage Iib-Iiib Squamous Cell Cervical Cancer Receiving Paclitaxel Cisplatin Chemotherapy Regimen by Eortc QLQ-C30 Questionnaire in Sanglah Hospital Denpasar

Noviyani

Indrayathi

Budiana

et al. 2017

Int J Pharm Pharm Sci

View full text Add to dashboard Cite

show abstract

“…Patients with stage IV disease had the lowest mean scores for global health status and emotional functioning and patients with stage III disease had the lowest mean score for role functioning and highest mean score for pain. 35 In the last, most recently published study 36 investigators identified factors which were significantly associated with poor quality of life (QOL) among California, USA cervical cancer survivors diagnosed 9-30 months prior, which captures the re-entry phase of survivorship. Compared to a US reference population, cervical cancer patients reported lower QOL and significantly higher levels of depression and anxiety (26% and 28% >1 SD above the general population means respectively).…”

Section: Methodsmentioning

confidence: 99%

Cervical Cancer Survivorship: Long-term Quality of Life and Social Support

Pfaendler

Wenzel

Mechanic

et al. 2015

Clinical Therapeutics

135

106

View full text Add to dashboard Cite

Purpose Surgery, radiotherapy and chemotherapy are the mainstays of cervical cancer treatment. Many patients receive multiple treatment modalities, each with its own long-term effects. Given the high 5 year survival rate for cervical cancer patients, evaluation and improvement of long-term quality of life are essential. Methods Pertinent articles were identified through searches of PubMed for literature published from 1993-2014. We summarize quality of life data from long-term follow up studies of cervical cancer patients. We additionally summarize small group interviews of Hispanic and non-Hispanic cervical cancer survivors regarding social support and coping. Findings Data is varied in terms of the long term impact of treatment on quality of life but consistent in suggesting that patients who receive radiotherapy as part of their treatment have the highest risk of increased long term dysfunction of bladder and bowel, as well as sexual dysfunction and psychosocial consequences. Rigorous investigations regarding long-term consequences of treatment modalities are lacking. Implications Continued work to improve treatment outcomes and survival should also include a focus on reducing adverse long-term side effects. Providing supportive care during treatment, and evaluating the effects of supportive care, may reduce the prevalence and magnitude of long-term sequelae of cervical cancer, which will in turn improve quality of life and quality of care.

show abstract

“…A cross-sectional investigation was carried out among cervical cancer patients revealed a significant decline in all QOL domains in women having Stage IV tumors. [18] Moreover, support from family and health-care workers (HCWs) reported to have better QOL outcomes in cancer patients. [1920]…”

Section: Introductionmentioning

confidence: 99%

Quality of life and its determinants in adult cancer patients undergoing chemotherapy treatment in Pakistan

Chagani

Parpio

Gul

et al. 2017

Asia-Pacific Journal of Oncology Nursing

View full text Add to dashboard Cite

Objective:Cancer is a leading cause of death worldwide. Likewise, in Pakistan, it is a major health problem, with an approximate increase each year. Cancer treatment, particularly chemotherapy, produces a detrimental effect on individuals’ well-being. Since the past few years, quality of life (QOL) is considered as the primary goal of cancer treatment in patients’ survival. This study aimed to assess the QOL and its determinants in adult cancer patients undergoing chemotherapy treatment.Methods:An analytical cross-sectional design was employed to achieve the study objectives, utilizing consecutive sampling technique. A total of 150 adult (>19 years) cancer patients were recruited from a Tertiary Care Hospital in Karachi, Pakistan. The data were collected using the Functional Assessment of Cancer Therapy-General, a QOL questionnaire. Multiple linear regression was run to determine the effect of predictor variables, with a mean QOL score.Results:The overall mean score of QOL as 57.37. The domains of physical and emotional well-being were mainly affected by the chemotherapy treatment. Variables such as no previous hospitalization and no significant changes in life events were positively associated with the QOL. On the other hand, being female, unemployed, chemotherapy side effects (>1 week), impaired socialization, and discrimination by family/relatives were negatively associated with the QOL.Conclusions:The study findings suggested an overall low QOL among adult cancer patients undergoing chemotherapy treatment. It is recognized as a stressful treatment, which adversely affects the QOL of cancer patients. Interventions should focus on both the physical and psychological issues and need to be addressed to improve the QOL of adult cancer patients.

show abstract

Quality of Life by Stage of Cervical Cancer among Malaysian Patients

Cited by 20 publications

References 19 publications

Assessment of Life Quality in Patients With Stage Iib-Iiib Squamous Cell Cervical Cancer Receiving Paclitaxel Cisplatin Chemotherapy Regimen by Eortc QLQ-C30 Questionnaire in Sanglah Hospital Denpasar

Assessment of Life Quality in Patients With Stage Iib-Iiib Squamous Cell Cervical Cancer Receiving Paclitaxel Cisplatin Chemotherapy Regimen by Eortc QLQ-C30 Questionnaire in Sanglah Hospital Denpasar

Cervical Cancer Survivorship: Long-term Quality of Life and Social Support

Quality of life and its determinants in adult cancer patients undergoing chemotherapy treatment in Pakistan

Contact Info

Product

Resources

About